I love the confidence in the board on the future success of the 5 path trials that increasing the value of RAC through NPP is no longer a consideration, and instead are happy to provide Bisantrene on compassionate use.
Absolutely unreal and great morals shown in the leaders of the company.
IMO, etc...
-
- There are more pages in this discussion • 2,679 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
-0.050(3.75%) |
Mkt cap ! $223.2M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $125.2K | 96.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 21173 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 6431 | 2 |
View Market Depth
| Last trade - 15.34pm 23/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |